TAIM
TD Ameritrade Investment Management Portfolio holdings
AUM
$9.4B
1-Year Return
7.2%
This Quarter Return
+3.07%
1 Year Return
+7.2%
3 Year Return
+13.51%
5 Year Return
+19.68%
10 Year Return
+53.59%
AUM
$14.3B
AUM Growth
+$2.09B
(+17%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
62.93%
Holding
753
New
112
Increased
259
Reduced
236
Closed
137
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$317M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$174M |
| 3 |
Vanguard Total Bond Market
BND
|
+$93.9M |
| 4 |
iShares S&P 500 Growth ETF
IVW
|
+$51.9M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$48.3M |
Top Sells
Sector Composition
| 1 | Financials | 0.11% |
| 2 | Technology | 0.1% |
| 3 | Healthcare | 0.1% |
| 4 | Industrials | 0.06% |
| 5 | Communication Services | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
OGE Energy
OGE
$8.75B
| $14K | ﹤0.01% |
355
-292
| -45% | -$11.5K |
|
452
Southern Company
SO
$99.9B
| $14K | ﹤0.01% |
199
-6,118
| -97% | -$430K |
|
453
Simon Property Group
SPG
$59.6B
| $14K | ﹤0.01% |
87
-219
| -72% | -$35.2K |
|
454
Teva Pharmaceuticals
TEVA
$22.1B
| $14K | ﹤0.01% |
1,752
+1,359
| +346% | +$10.9K |
|
|
SYNH
455
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $14K | ﹤0.01% |
+139
| New | +$14K |
|
456
Advanced Micro Devices
AMD
$246B
| $13K | ﹤0.01% |
+89
| New | +$13K |
|
457
FMC
FMC
$4.73B
| $13K | ﹤0.01% |
118
+56
| +90% | +$6.17K |
|
458
Icon
ICLR
$13.8B
| $13K | ﹤0.01% |
42
-11
| -21% | -$3.41K |
|
459
Medical Properties Trust
MPW
$2.75B
| $13K | ﹤0.01% |
536
+11
| +2% | +$267 |
|
460
Insulet
PODD
$24.6B
| $13K | ﹤0.01% |
49
+41
| +513% | +$10.9K |
|
461
PayPal
PYPL
$65.3B
| $13K | ﹤0.01% |
67
+32
| +91% | +$6.21K |
|
462
Hanover Insurance
THG
$6.36B
| $13K | ﹤0.01% |
+96
| New | +$13K |
|
463
Agilent Technologies
A
$36.3B
| $12K | ﹤0.01% |
+76
| New | +$12K |
|
464
Avery Dennison
AVY
$13.1B
| $12K | ﹤0.01% |
+57
| New | +$12K |
|
465
BioMarin Pharmaceuticals
BMRN
$10.8B
| $12K | ﹤0.01% |
139
+95
| +216% | +$8.2K |
|
466
Deere & Co
DE
$130B
| $12K | ﹤0.01% |
36
-335
| -90% | -$112K |
|
467
Leggett & Platt
LEG
$1.38B
| $12K | ﹤0.01% |
282
-10,603
| -97% | -$451K |
|
468
Take-Two Interactive
TTWO
$45.9B
| $12K | ﹤0.01% |
+65
| New | +$12K |
|
469
Vanguard Small-Cap ETF
VB
$67.3B
| $12K | ﹤0.01% |
54
+29
| +116% | +$6.44K |
|
470
Dayforce
DAY
$10.9B
| $12K | ﹤0.01% |
114
+89
| +356% | +$9.37K |
|
471
Alibaba
BABA
$337B
| $11K | ﹤0.01% |
91
-48
| -35% | -$5.8K |
|
472
CAE Inc
CAE
$8.54B
| $11K | ﹤0.01% |
452
-503
| -53% | -$12.2K |
|
473
Chemours
CC
$2.43B
| $11K | ﹤0.01% |
+331
| New | +$11K |
|
474
Equifax
EFX
$31.2B
| $11K | ﹤0.01% |
37
+24
| +185% | +$7.14K |
|
475
Humana
HUM
$37.3B
| $11K | ﹤0.01% |
23
+15
| +188% | +$7.17K |
|